article thumbnail

With Phase 2 Data in Hand, Ovid Eyes Multiple Pivotal Trials for Epilepsy Drug

Xconomy

That research is starting to pay off as the companies now look ahead to pivotal studies testing that compound in several inherited forms of the disorder. The study was small and was not designed to show statistical significance. The study was small and was not designed to show statistical significance.

article thumbnail

Reneo Readies for Global Test of Drug for Rare Mitochondrial Disease

Xconomy

Reneo Pharmaceuticals has encouraging results from an early trial of a compound it is advancing for rare diseases characterized by impaired mitochondria—our cells’ energy generators—and the company says it is now designing a large global study of its drug candidate.

San Diego 127
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Bio Roundup: COVID-19 Trials, Esperion’s Approvals, NASH News & More

Xconomy

A trial is designed, conducted according to that design, and then results are analyzed. Making changes in the midst of the study was a no-no. In recent years, regulators have showed openness to clinical trial designs intended to make drug testing more efficient. Clinical trials have historically hewn to a rigid format.

News 89
article thumbnail

10 Keys To A Credible and Trusted Internet Web Domain

Startup Professionals Musings

Publish a regular blog, contribute to relevant social networks, and highlight several videos, podcasts, or eBooks of you and your technology. Professional user-friendly site design. No name, picture, address, or business history only convinces customers that you are hiding, located in an un-trustable country, or don’t have a clue.

Web 117
article thumbnail

Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch

Xconomy

million from new investors, including the New York-based Juvenile Diabetes Research Foundation, following the results of a clinical study of its experimental biomarker monitoring device. Biosensor startup Biolinq said Thursday it has raised $4.75 The company began focusing on the technology it is currently developing in 2015, Tagney said.

San Diego 103
article thumbnail

Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests

Xconomy

The Boston company, which counts diabetes drug giants Eli Lilly (NYSE: LLY ) and Novo Nordisk (NYSE: NVO ) among its investors and partners, says the capital will support Phase 3 studies of its device this year, and if all goes well, an application for FDA approval. Beta Bionics’s device is designed to mimic the role of.

Study 87
article thumbnail

Google Launching Its Own Computer Science Courses on Campuses

Xconomy

Early next year, twenty students will have the opportunity to study machine learning for 10 weeks with Google engineers, college professors, and coaches—free of charge. The bootcamp-like machine learning course is part of a broader Google initiative to bring computer science instruction that it designs.

Course 94